Abstract
Background
Metabolic and bariatric surgery (MBS) is a highly effective treatment for patients with obesity, with increasing prevalence in France. However, some patients require revisional MBS (RMBS) due to suboptimal initial response, recurrent weight gain, and correction of technique-related complications. Understanding the prevalence and risks associated with RMBS is essential for optimizing patient care.
Objective
This study aims to assess the rate of RMBS in France and to delineate the associated complications and risk factors.
Setting
France.
Methods
Using national discharge data from 2016 to 2022, this observational study compared morbidity and mortality rates between primary and RMBS. Patient demographics, comorbidities, and procedural details were analyzed. Major complications within 90 days post-surgery were assessed using logistic regression models adjusted for potential confounders.
Results
Among 284,271 bariatric procedures analyzed, the revision rate was 12.8%. Patients undergoing RMBS were older, predominantly female, and had more comorbidities compared to those undergoing primary procedures. RMBS were associated with significantly higher rates of severe complications (OR 1.58, 95% CI 1.49–1.68, p < 0.001), particularly after gastric bypass (GB) (OR 2.70, 95% CI 2.27–3.20). Subgroup analyses showed increased morbidity following revisional sleeve gastrectomy compared to primary procedures.
Conclusions
This study highlights a notable rate of RMBS in France, with evolving trends towards more complex revisions. RMBS are associated with increased morbidity, emphasizing the need for careful patient selection and enhanced postoperative management. Further research into surgical techniques, long-term pharmacological interventions, and surgeon expertise is warranted to optimize outcomes in this population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
All datasets on which the conclusions of the paper rely should be available to readers. The data is available at Nantes University Hospital.
References
Fontbonne A, Currie A, Tounian P, Picot M-C, Foulatier O, Nedelcu M, et al. Prevalence of overweight and obesity in france: the 2020 Obepi-Roche study by the “Ligue Contre l’Obésité”. J Clin Med. 2023;12:925.
Lazzati A, Bechet S, Jouma S, Paolino L, Jung C. Revision surgery after sleeve gastrectomy: a nationwide study with 10 years of follow-up. Surg Obes Relat Dis. 2020;16:1497–504.
Brown WA, Liem R, Al-Sabah S, Anvari M, Boza C, Cohenet V, et al. IFSO global registry collaboration. metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report. Obes Surg. 2024;34:1764–77.
Mann JP, Jakes AD, Hayden JD, Barth J. Systematic review of definitions of failure in revisional bariatric surgery. Obes Surg. 2015;25:571–4.
Nasta AM, Goel R, Singhal R, Lemmens L, Baig S, Seki Y, et al. 30-day morbidity and mortality of revisional bariatric surgery - An international multi-centre collaborative (BROAD) study. Obes Res Clin Pract. 2024;18:195–200.
Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc J-L, Sailler L. French health insurance databases: what interest for medical research? Revue Med Interne. 2015;36:411–7.
Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merlière Y. French national health insurance information system and the permanent beneficiaries sample. Rev Épidémiol Santé Publique. 2010;58:286–90.
Bousquet C, Souvignet J, Merabti T, Sadou E, Trombert B, Rodrigues J-M. Method for mapping the French CCAM terminology to the UMLS metathesaurus. Stud Health Technol Inform. 2012;180:164–8.
Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.
Clapp B, Wynn M, Martyn C, Foster C, O’Dell M, Tyroch A. Longterm (7 or more years) outcomes of the sleeve gastrectomy: ameta-analysis. Surg Obes Relat Dis. 2018;14:741–7.
Felsenreich DM, Ladinig LM, Beckerhinn P, Sperker C, Schwameis K, Krebs M, et al. Update:10 years of sleeve gastrectomy—The first 103 patients. ObesSurg. 2018;28:3586–94.
Mahawar KK, Graham Y, Carr WRJ, Jennings N, Schroeder N, Balupuriet S, et al. Revisional Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review of comparative outcomes with respective primary procedures. Obes Surg. 2015;25:1271–80.
Axer S, Szabo E, Agerskov S, Näslund I. Predictive factors of complications in revisional gastric bypass surgery: results from the Scandinavian obesity surgery registry. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2019;15:2094–100.
El Chaar M, Stoltzfus J, Melitics M, Claros L, Zeido A. 30-day outcomes of revisional bariatric stapling procedures: first report based on MBSAQIP data registry. Obes Surg. 2018;28:2233–40.
Pedziwiatr M, Malczak P, Wierdak M, Rubinkiewicz M, Pisarska M, Major P, et al. Revisional gastric bypass is inferior to primary gastric bypass in terms of short-and long-term outcomes-systematic review and meta-analysis. Obes Surg. 2018;28:2083–91.
Salman M, Salman M, Elewa A, Elsherbiny M, Tourkey M, Chikukuza S, et al. Outcomes of revisional surgery options after inadequate sleeve gastrectomy: a comprehensive network meta-analysis. World J Surg. 2024;48:2040–57.
Spurzem GJ, Broderick RC, Kunkel EK, Hollandsworth H, Sandler B, Jacobsen G, et al. Robotic bariatric surgery reduces morbidity for revisional gastric bypass when compared to laparoscopic: outcome of 8-year MBSAQIP analysis of over 40,000 cases. Surg Endosc. 2024;38:6294–304.
Redmond IP, Shukla AP, Aronne LJ. Use of weight loss medications in patients after bariatric surgery. Curr Obes Rep. 2021;10:81–9.
Miras AD, Pérez-Pevida B, Aldhwayan M, Kamocka A, McGlone E, Al-Najim W, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7:549–59.
Author information
Authors and Affiliations
Contributions
CB participated in conception and design, data acquisition and analysis, and manuscript redaction. AL participated in conception and design, in statistical analysis, and manuscript redaction. CT and GG participated in data acquisition and revised the manuscript critically for important intellectual content.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lazzati, A., Tresallet, C., Guian, G. et al. Investigating the trend of revisional bariatric surgery, the complications, and associated risk factors in France. Int J Obes 50, 647–653 (2026). https://doi.org/10.1038/s41366-025-01990-4
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41366-025-01990-4

